Escherichia coli ribonuclease III cleaves adenovirus messenger RNA and mammalian 28S and ISS ribosomal RNA. Fragmentation is not random, but in each case a specific collection of products is generated. This points to the potential use of the enzyme as a tool for specific fragmentation of RNA. Cleavage by RNase III abolishes the capability of adenovirus messenger RNA to direct cell-free synthesis of virus polypeptides.
RNase III, an enzyme found in extracts of Escherichua coli, was originally thought to act exclusively on double-stranded RNA (1) generating oligonucleotides (2) (3) (4) . Recently, however, considerable attention has been focused on the fact that precursors of both bacterial (5) (6) (7) (8) and eukaryotic (9) rRNA, as well as the primary transcripts of early T7 DNA (6, 10, 11) , are cleaved by the enzyme into fragments which are indistinguishable from those observed in vivo, implying a role for RNase III in the processing of RNA. At first sight, nearly complete degradation of doublestranded RNA and precise fragmentation of rRNA precursors or T7 transcripts are seemingly unrelated features of one enzyme. Yet, these two properties appear to copurify both genetically (5) and biochemically (4) . It has been suggested that hairpin loops within the RNA molecule may be recognized by the enzyme (11, 12) , possibly in conjunction with some signals conveyed by the primary structure next to the cleavage site (10, 8) . Thus, base-paired regions of RNA may be the common denominators for recognition by RNase III.
Helical structures have been most elegantly visualized in precursors of mammalian rRNA (13) , and may be common as well to messenger RNA (14) . A gradient of susceptibility of RNA sites to RNase III cleavage may be envisaged, with primary sequence and steric conformation determining the various degrees of exposure to enzymatic attack. While the signals for initial processing of large T7 transcripts and rRNA precursors are strong enough to elicit prompt response by the enzyme, more vigorous cleavage conditions may be needed for less exposed sites. Using three RNAs, adenovirus type 2 (Ad2) mRNA, 28S rRNA, and 18S rRNA, we will show here that unique patterns of fragments indeed result from cleavage by high doses of RNase III.
MATERIALS AND METHODS
RNase III was prepared as described (3) . Upon isoelectric focusing of the material, one major band appears (R. J. Crouch, unpublished) (15) , with the following modifications. The assays contained up to 15 ng of exogenous mRNA per ll, 3.6 mM magnesium acetate, and 100 mM KC1. Translation products were analyzed by electrophoresis on 13% sodium dodecyl sulfate/polyacrylamide gels, and the radioactivity contained in bands of individual viral polypeptides was determined as reported (15) . KB Cell rRNA. Growing cells were washed with, and resuspended in, phosphate-free medium containing 2% dialyzed fetal calf serum and 10 mM Hepes (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid), added to stabilize the pH (17) . After 2 hr, 5 mCi of carrier-free 32pO4 was added to a culture containing 3 X 107 cells in 50 ml of medium, and 24 hr later cytoplasmic RNA (0.2 mg; 6 X 105 cpm/,ug) was prepared (15) . Individual species of rRNA were gained by fractionation of cytoplasmic RNA on 15-30% neutral sucrose gradients (16) . Fractionated RNA was precipitated with ethanol, redissolved in H20 at 70 jig/ml, and stored for several weeks in liquid nitrogen, without noticeable degradation.
RESULTS
Electrophoresis of RNA fragments cleaved from Ad2 mRNA and KB cell rRNA The observation of hairpin loops in ribosomal (13) al bands which, although visible in the original autoradiogram, were poorly resolved in the photograph (Fig. 2, column 1) . Nevertheless, the shift of RNA radioactivity toward greater electrophoretic mobility after enzyme treatment (Fig. 2, column 2 ) was obvious.
Much more distinct were the patterns of RNA fragments resulting from the treatment of purified 28S rRNA (Fig. 2 , column 4) with RNase III. Whereas, a low dose of enzyme produced fragments that migrated in several bands, some between 28S and 18S rRNA markers, one near the bottom of the gel (Fig. 2, column 5) , a high amount of enzyme resulted in further fragmentation, as evidenced by a number of bands displayed in the lower half of Fig. 2, column 6 . No radioactivity remained at the origin, indicating that all 28S rRNA had been cleaved. On the other hand, 18S rRNA ap- peared more resistant to RNase III attack, with only a portion of the RNA cleaved into fragments which formed a pattern distinct from that of 28S rRNA cleavage products. Translation of RNase Ill-treated Ad2 mRNA A number of virion polypeptides are synthesized in cell-free systems directed by late Ad2 mRNA (15, 18, 19, 16, (20) (21) (22) . In an attempt to correlate the observed fragmentation of the RNA by RNase III with its biological activity, we translated enzyme-treated Ad2 mRNA in an S30 extract of Krebs II ascites cells. This cell-free system had a considerable background of endogenous protein synthesis in the absence of added mRNA, as demonstrated in column f of Fig. 3 , displaying the electrophoretic pattern of polypeptides synthesized in the control assay. Polypeptide migration was toward the bottom of the gel, separating polypeptides in the size range of >105 to about 104 daltons. Addition of 30 ng of Ad2 mRNA to the cell-free system resulted in the synthesis of a number of virion protein components, some of which could easily be discerned (column a, Fig. 3 ) using adenovirion polypeptides (column M) as a reference. Treatment of Ad2 mRNA with increasing doses of RNase III prior to cellfree translation led to the gradual disappearance of the polypeptides specified by Ad2 mRNA (columns b through e).
Yet, the sensitivity of in vitro expression to enzyme attack varied considerably among individual virus-specific polypeptides. For instance, the amount of RNase III required for a 50% reduction in the synthesis of polypeptide pVII, the precursor (23) of core protein VII, was more than twice that needed to reduce hexon (= polypeptide II) synthesis to the same level (Fig. 4) .
Ad2 mRNAs coding for individual components of the virus particle have been partially separated by sucrose gradient centrifugation (18, 22, 20) . The size of some of these mRNAs, estimated from their sedimentation velocities, exceeds that required to specify the respective polypeptide. For instance, pVII, a small polypeptide of 20,000 molecular weight (23) , is expressed by an RNA of perhaps as much as five times (18) (18) . If so, treatment of Ad2 mRNA with RNase III might generate fragments that retain the coding capacity for an entire virus polypeptide, provided the enzyme does not destroy signals required for proper translation.
Accordingly, we treated Ad2 mRNA with increasing amounts of RNase III (corresponding to assays a through e, Fig. 3 ), fractionated the cleavage products by sucrose gradient centrifugation, and tested the RNA contained in individual gradient fractions in translation assays. The sedimentation profiles of the Ad2 mRNA (Fig. 5) showed a gradual shift of radioactivity from a position between 28S and 18S rRNA (assay a = Ad2 mRNA incubated in the absence of RNase III) to a position close to 4S (assay e = highest enzyme concentration). RNA contained in individual fractions of the sucrose gradient gave rise to the cell-free translation products displayed in the electropherograms at the left of Fig. 5 . The virus-specific protein that could be most readily discerned from the background of endogenous material is polypeptide II or hexon, visible as the top band in the columns corresponding to fractions 7-12 of panels a-d. Most of the mRNA giving rise to polypeptide II appeared to be contained in fractions 9-10, in quantities inversely proportional to the amounts of enzyme used. Like polypeptide II, none of the smaller virus-specific polypeptides, such as polypeptides III, IV, or pVII, varied in position in the sucrose gradient, no matter which concentration of RNase III had been used (note that pVII is present, albeit poorly resolved, in panels a and c); moreover, no additional polypeptide bands were detectable among the translation products of RNase III-treated Ad2 mRNA. Thus, we were unable to detect fragments of Ad2 mRNA that retained their ability to specify cell-free translation products. (Fig. 3) were sedimented through sucrose gradients (see Fig. 1 ), and the radioactivity of 0.25 volume of each gradient fraction was determined in scintillation fluid. The RNA sedimentation profiles appear at the right side-of the figure. The remainders of the sucrose gradient fractions were combined, as indicated at the left of the abscissa, adjusted to 0.15 M KCl, and precipitated by ethanol, together with 4 ,ug of carrier rabbit tRNA (General Biochemicals). The samples were centrifuged overnight at -20°in a swing-out rotor at 1800 X gmax, washed with 70% (v/v) ethanol in water, recentrifuged for 30 min, dried, and taken up in 60 ,ul of translation mixture. The 35S-labeled products of the cellfree translations were electrophoresed on standard 13% sodium dodecyl sulfate/polyacrylamide gels (15) . The autoradiograms of these gels, shown on the left side of the figure, include adenovirion marker proteins (M), aliquots of the translation assays of Fig. 3 (A), and translation assays lacking exogenous mRNA (B). Roman numerals at the left ordinate refer to individual adenovirus polypeptides (see Fig. 3 ).
DISCUSSION
We have made no attempts to account for fragments of oligonucleotide size and, therefore, have not data to support the mechanism of cleavage envisioned here. In any event, RNase III treatment of Ad2 mRNA did not generate significant amounts of radioactivity remaining on top of the sucrose gradients (Fig. 5) (24) . Evidence has accumulated which suggests that eukaryotic mRNA contains more information than is necessary to encode for the cognate protein (25) (26) (27) (28) (29) 36) . The function(s) of such extra RNA is, as yet, unknown. It is conceivable that the rapid inactivation of Ad2 mRNA to act as a message in a cell-free system after treatment with RNase III reflects a preference of the enzyme for sites present in the extra RNA regions and not an attack in the coding sequence. Certainly if RNase III action separates the coding sequence from any signal required for translation, the RNA would be inactivated without the necessity of a cleavage in the region of the encoded message. Recently, Both et al. (30) have proposed that the 5'-terminal 7-methyl guanosine is necessary for efficient translation of vesicular stomatitis virus and reovirus mRNA. If the Ad2 mRNA has a similar requirement, simply removing a few nucleotides from the 5' terminus would render the mRNA inactive for in vitro protein synthesis. The greater the distance the coding sequence is from the 5'-terminal methylated nucleotide, the greater is the chance for separation of the translated sequence and the 5' terminus. Even though the mRNA for pVII sediments as if the RNA is five times (18) the pVII code size, we find the mRNA, after treatment with RNase III, in a translatable form only in the region of the sucrose gradient in which untreated pVII mRNA is found. Such an observation is consistent with either a direct inactivation of the pVII mRNA by nucleolytic action in the coding sequence or by a severing of the translatable sequence from a structure or sequence necessary for proper translation. In light of this consideration, the preservation of translatable Ad2 mRNA sequences after RNase III attack would seem indeed unlikely.
The in vitro synthesis of the hexon polypeptide is more affected by RNase III action than that of pVII, the precursor to core polypeptide VII. Hexon mRNA sediments ahead of pVII mRNA in sucrose gradients. This suggests that, as the larger target, it is more vulnerable to RNase III attack. Alternatively, or in addition, the Ad2 mRNA preparation may contain more copies of pVII mRNA than of hexon mRNA, or hexon mRNA may harbor sites more sensitive to RNase III than those of pVII mRNA.
The list of RNases of both prokaryotic (31) and eukaryotic (32, 33) origin with limited and specified endonucleolytic action is growing rapidly. Even RNase T1, when tested under restricted conditions (34) , may be included in this list. This area of research may be expected to bring deeper insight into the various pathways of RNA processing and degradation and their regulation in vivo while generating more refined methods for RNA analysis in vitro.
